Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04162938 · ClinicalTrials.gov registry record · NA

Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum

A NA study of Hepatitis C, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
308
Enrollment target
1
Study location

NCT04162938: Recruiting NA study of Hepatitis C, sponsored by Johns Hopkins University.

NCT04162938 is a NA study of Hepatitis C that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 308 participants, below the 1,887-participant average among 106 other Hepatitis C trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04162938, a NA study of Hepatitis C, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
308 participants
Enrollment target
1
Study location

Study Summary

The investigators will conduct a randomized controlled clinical trial study in an urban emergency department in Baltimore to determine the impact of an educational app which is based on Leventhal's Common-Sense Model of Illness Representations framework, on HCV-infected ED patient's hepatitis C virus (HCV) health belief and knowledge as well as the downstream outcomes of the HCV Continuum of Care (linkage to care rate, initiation of HCV antiviral treatment, and sustained virologic response). First, the investigators will develop a blueprinted prototype personalized HCV educational app which will (1) provide individualized liver fibrosis staging information, (2) pre-test HCV knowledge, perception of barriers to HCV care, and motivation to receive HCV care survey, (3) provide personalized HCV knowledge, facilitators and supporting information for HCV care via video clips and information sheets based on the pre-test results, and (4) provide post-test knowledge, perception, and motivation to receive HCV care. Second, the investigators will conduct a series of focus group discussion sessions to fine-tune the HCV educational app. Third, the investigators will enroll ED patients who have anti-HCV (newly diagnosed or previously diagnosed) but without HCV RNA testing information for a pilot randomized controlled clinical trial of the personalized HCV educational app.

Primary Outcome

Linkage to care rate is defined as the time (days) between patient enrollment and the patient's first HCV-related clinic visit.

Conditions Studied

Interventions

  • OTHER Patient-Centered Electronic App

Study Locations (1)

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 308 participants
Start Date 2022-03-24
Est. Completion 2026-09
Phase NA
Johns Hopkins University

1,448 total trials

What NCT04162938 shows while recruiting

NCT04162938 is an interventional study that assigns participants to a tested intervention. The registered 308 participants enrollment target is mid-sized for trials with a published cap, below the 1,887-participant average among 106 other Hepatitis C trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Hepatitis C appearing as the primary indexed condition, and to 1 intervention - of which Patient-Centered Electronic App is the first listed.

NCT04162938 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT04162938 about?

NCT04162938 is a clinical study titled "Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum". The investigators will conduct a randomized controlled clinical trial study in an urban emergency department in Baltimore to determine the impact of an educational app which is based on Leventhal's Common-Sense Model of Illness Representations framework, on HCV-infected ED patient's hepatitis C viru...

What is the current status of trial NCT04162938?

This trial is currently recruiting. It is a NA study. The enrollment target is 308 participants. The study started on 2022-03-24. Estimated completion is 2026-09.

What conditions does trial NCT04162938 study?

This clinical trial studies the following conditions: Hepatitis C.

What interventions are being tested in trial NCT04162938?

The interventions under investigation include: Patient-Centered Electronic App (OTHER).

Who is sponsoring clinical trial NCT04162938?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04162938 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04162938's enrollment target sits among peer trials

308 37th of 106 higher than 70 of 106 other Hepatitis C trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hepatitis C trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04955795 · 308 participants · NA

    Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA

  • NCT06090539 · 308 participants · Phase 1

    A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

  • NCT06233942 · 308 participants · Phase 1

    Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

  • NCT06319248 · 308 participants · Phase 2

    MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04162938, the US trial registry maintained by the National Library of Medicine. NCT04162938 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.